1. Home
  2. BVS vs JRI Comparison

BVS vs JRI Comparison

Compare BVS & JRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • JRI
  • Stock Information
  • Founded
  • BVS 2011
  • JRI 2012
  • Country
  • BVS United States
  • JRI United States
  • Employees
  • BVS N/A
  • JRI N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • JRI Finance Companies
  • Sector
  • BVS Health Care
  • JRI Finance
  • Exchange
  • BVS Nasdaq
  • JRI Nasdaq
  • Market Cap
  • BVS 432.7M
  • JRI 367.7M
  • IPO Year
  • BVS 2021
  • JRI N/A
  • Fundamental
  • Price
  • BVS $7.23
  • JRI $14.23
  • Analyst Decision
  • BVS Strong Buy
  • JRI
  • Analyst Count
  • BVS 5
  • JRI 0
  • Target Price
  • BVS $14.40
  • JRI N/A
  • AVG Volume (30 Days)
  • BVS 388.8K
  • JRI 68.0K
  • Earning Date
  • BVS 11-04-2025
  • JRI 01-01-0001
  • Dividend Yield
  • BVS N/A
  • JRI 9.38%
  • EPS Growth
  • BVS N/A
  • JRI N/A
  • EPS
  • BVS 0.03
  • JRI N/A
  • Revenue
  • BVS $564,142,000.00
  • JRI N/A
  • Revenue This Year
  • BVS N/A
  • JRI N/A
  • Revenue Next Year
  • BVS $6.84
  • JRI N/A
  • P/E Ratio
  • BVS $261.09
  • JRI N/A
  • Revenue Growth
  • BVS 5.08
  • JRI N/A
  • 52 Week Low
  • BVS $5.81
  • JRI $9.70
  • 52 Week High
  • BVS $14.38
  • JRI $12.12
  • Technical
  • Relative Strength Index (RSI)
  • BVS 52.04
  • JRI 82.42
  • Support Level
  • BVS $6.98
  • JRI $13.27
  • Resistance Level
  • BVS $7.33
  • JRI $13.60
  • Average True Range (ATR)
  • BVS 0.27
  • JRI 0.11
  • MACD
  • BVS -0.03
  • JRI 0.07
  • Stochastic Oscillator
  • BVS 32.89
  • JRI 99.77

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About JRI Nuveen Real Asset Income and Growth Fund of Beneficial Interest

Nuveen Real Asset Income and Growth Fund is the United States-based closed-end fund. Its objective is to provide a high level of current income and long-term capital appreciation. The fund invests a majority of its managed assets in equity and debt securities issued by real asset related companies located anywhere in the world. Its plan involves investments in five security types, infrastructure common stock, REIT preferred stock and debt securities. Real asset-related companies include those engaged in owning, operating, or developing infrastructure projects, facilities, and services, as well as REITs.

Share on Social Networks: